• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
IMGN

IMGN

ImmunoGen, Inc.

NASDAQHealthcareBiotechnologyUS

USD31.23

+0.01 (+0.02%)

Company Profile

CEO

Mark Joseph Enyedy

IPO Date

1989-11-17

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$31.24

Prev. Close

$31.23

Day Low

$31.22

Day High

$31.25

52W Low

$3.61

52W High

$31.25

Market Cap

$8.73B

Volume

19.31M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

22.1%

Avg Negative

23.2%

Avg Neutral

54.8%

News Feed

ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/30/2021·↓ negative

ImmunoGen (IMGN) Reports Q2 Loss, Misses Revenue Estimates

Zacks Investment Research·7/30/2021·↑ positive

ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results

Business Wire·7/30/2021·↑ positive

ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual Healthcare Conference

Business Wire·5/20/2021·↑ positive

ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/10/2021·↓ negative

ImmunoGen (IMGN) Q1 Earnings Top, Pivotal Studies Delayed

Zacks Investment Research·5/10/2021·↓ negative

ImmunoGen (IMGN) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research·5/10/2021·↑ positive

Immunogen: Q1 Earnings Insights

Benzinga·5/10/2021·↓ negative

ImmunoGen Reports Recent Progress and First Quarter 2021 Financial Results

Business Wire·5/10/2021·↑ positive

ImmunoGen: Turning Around Amid A Bearish Environment

Seeking Alpha·4/28/2021·↑ positive